Neurogen stockholders

Related by string. * : PRNewswire FirstCall Neurogen . Neurogen disclaims . Neurogen disclaims any . Neurogen Corporation . Neurogen conducts . Neurogen / Stockholders . STOCKHOLDERS : LIABILITIES AND STOCKHOLDERS EQUITY . Stockholders Equity Current liabilities . Total stockholders . Stockholders Approve Merger . stockholders . TOTAL LIABILITIES AND STOCKHOLDERS * *

Related by context. Frequent words. (Click for all words.) 62 Merger Transaction 62 Files Shelf Registration Statement 61 Accelerated Share Repurchase 61 Repurchase Program 60 Combination Agreement 59 liquidating distributions 59 Shareholder Approval 59 Second Tranche 59 Stockholder Rights Plan 59 Stock Repurchase Plan 59 NASDAQ Listing Rules 59 unvested options 59 Sunesis Pharmaceuticals 58 Amended Agreement 58 Stockholders Approve Merger 58 C Convertible Preferred 58 disinterested shareholder 58 No. #R 57 BioDelivery Sciences 57 Convertible Debt 57 Cyclacel Pharmaceuticals 57 ACLARA 57 secured convertible debenture 57 NASDAQ CYPB 57 Shelf Registration Statement 57 NASDAQ LGND 57 Debt Conversion 57 Declares Quarterly Dividends 56 Stockholders Approve 56 pro rata portion 56 vesting provisions 56 finder fee payable 56 ProUroCare 56 Debenture holders 56 symbol TOL 56 Share Repurchase Plan 56 stockholder approvals 56 Proposed Qualifying Transaction 56 Restricted Share 56 Mandatory Convertible Preferred Stock 56 Comamtech 56 No. #R Share 56 Brokered Offering 56 convertible promissory notes 56 Debt Tender Offer 56 Private Placement Offering 56 Option Grants 56 Tikcro 55 Warrantholders 55 Subordinated Note 55 Flow Through Offering 55 AXEA 55 Nasdaq VRTX 55 Subordinate Voting Stock 55 Agent Warrant 55 Committed Equity 55 subordinated indebtedness 55 issuable pursuant 55 pershare 55 underwriters overallotment option 55 AAMAC 55 stockholder approval 55 Cash Consideration 55 Med BioGene 55 Securities Purchase Agreement 55 Concurrent Financing 55 Warrant Exercise 55 Cyries 55 #R Share Based 55 Stock Repurchase Program 55 Merger Proposal 55 Inc. NASDAQ THRX 55 CPIF 54 Reverse Stock 54 Completes Tender Offer 54 secured convertible debentures 54 Apthera 54 B Preferred Stock 54 Inergy Holdings 54 intangible assets impairment 54 Each Finder Warrant 54 Senior Secured Term 54 Caremark stockholders 54 Convertible Perpetual Preferred Stock 54 Extends Tender Offer 54 Annual Stockholder Meeting 54 c Represents 54 InKine 54 CVRs 54 Announces Stockholder Approval 54 Annual Meeting Date 54 unvested restricted stock 54 Ardea Biosciences 54 indebtedness incurred 54 Innovive 54 convertible subordinated debentures 54 Dynegy stockholders 54 Universal Shelf Registration 54 issuable upon exercise 54 applicable Total Consideration 54 ACADIA Pharmaceuticals

Back to home page